Deutsche Bank
NAUT icon

Deutsche Bank’s Nautilus Biotechnolgy NAUT Stock Holding History

Deutsche Bank’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$60.2K Sell
42,421
-6,097
-13% -$7.24K ﹤0.01% 3452
2026
Q2 		$90.7K Buy
+48,518
New +$128K ﹤0.01% 3499
2025
Q2 		– Sell
-54,839
Closed -$47.2K – 3683
2025
Q1 		$47.2K Buy
54,839
+32,470
+145% +$48.3K ﹤0.01% 3385
2024
Q4 		$37.6K Hold
22,369
– – ﹤0.01% 3457
2024
Q3 		$63.8K Hold
22,369
– – ﹤0.01% 3313
2024
Q2 		$52.3K Hold
22,369
– – ﹤0.01% 3320
2024
Q1 		$65.8K Sell
22,369
-10,322
-32% -$29.3K ﹤0.01% 3327
2023
Q4 		$97.7K Hold
32,691
– – ﹤0.01% 3226
2023
Q3 		$103K Hold
32,691
– – ﹤0.01% 3146
2023
Q2 		$127K Sell
32,691
-8,706
-21% -$25.1K ﹤0.01% 3162
2023
Q1 		$115K Buy
41,397
+21,721
+110% +$45.6K ﹤0.01% 3271
2022
Q4 		$35.4K Buy
19,676
+318
+2% +$614 ﹤0.01% 3659
2022
Q3 		$41K Sell
19,358
-3,178
-14% -$7.99K ﹤0.01% 3643
2022
Q2 		$61K Buy
+22,536
New +$83.9K ﹤0.01% 3701

Other funds holding NAUT

Cercano Management
Cercano Management Bellevue, Washington $729M AUM 20.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Clearstead Advisors
Clearstead Advisors Cleveland, Ohio $10.8B AUM 17.88% 1-Year Est. Return
Sentinel Trust
Sentinel Trust Houston, Texas $1.19B AUM 19.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Deutsche Bank's NAUT Position: Q3 2026 in Review

Deutsche Bank reduced its Nautilus Biotechnolgy (NAUT) stake by 13% in Q3 2026, selling an estimated $7.24K and leaving 42,421 shares worth $60.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3452.

Deutsche Bank first reported a position in NAUT in Q2 2022 and has held it in 14 quarters since. The position peaked at $127K in Q2 2023. 59 funds tracked by Wall St. Rank hold NAUT as of Q3 2026.

  • Deutsche Bank held 42,421 shares of Nautilus Biotechnolgy worth $60.2K as of Q3 2026.
  • Deutsche Bank sold 6,097 Nautilus Biotechnolgy shares in Q3 2026, an estimated $7.24K.
  • Nautilus Biotechnolgy made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #3452 holding.
  • Deutsche Bank first reported a position in Nautilus Biotechnolgy in Q2 2022 and has held it in 14 quarters since.
  • Deutsche Bank's Nautilus Biotechnolgy position peaked at $127K in Q2 2023.
  • 59 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.